Active Pharmaceutical Ingredients Global Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2022

Active Pharmaceutical Ingredients (API) market accounted for $121.4 billion in 2014 and is expected to grow at a CAGR of 6.4% to reach $198.8 billion by 2022. Patent expiration of prominent drugs, government initiatives, regional penetration, increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.

Get sample copy of the Report:

The Global Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Anti-infectives application commanded the largest market share in 2014, whereas oncology is expected to be the fastest growing application with a CAGR of more than 8.8 during the forecast period.

Also Read:  Growth of Sweet Potatoes Market Attributed to Thriving Food & Beverages Industry

By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the global leader in the active pharmaceuticals ingredients market due to its highly developed research and development projects in the field of therapies, medical sciences, and drugs. Asia Pacific is projected to be the fastest growing regional market with a CAGR of more than 8%. The fast growth is attributed to patent expirations of drugs, and favourable investments in medical research.

Enquire about Discount on Report:

Table of Content:

1 Executive Summary 

2 Preface 
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis 
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Active Pharmaceutical Ingredients Market, By Types of API
5.1 Introduction
5.2 Synthetic chemical API
5.2.1 Branded/ Innovative
5.2.2 Generic/Non- Branded
5.3 Biological API
5.3.1 Biotech
5.3.2 Biosimilar
5.4 High potency active pharmaceutical ingredients(HPAPI)

6 Global Active Pharmaceutical Ingredients Market, By Type of manufacturing
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

Also Read:  E-commerce logistics provider Xpressbees raises $4.9 Mn from InnoVen Capital

7 Global Active Pharmaceutical Ingredients Market, By Therapeutic applications
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder

8 Global Active Pharmaceutical Ingredients Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Key Developments 
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling 
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (Canada)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac

Know more about Report:


Go to website